Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

24 Nov 2020
Change (% chg)

¥-0.02 (-0.61%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Harbin Pharmaceutical Swings To H1 Net Loss At 42.3 Million Yuan
Friday, 30 Aug 2019 

Aug 30 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS H1 NET LOSS AT 42.3 MILLION YUAN ($5.96 million) VERSUS NET PROFIT OF 363.0 MILLION YUAN YEAR EARLIER.  Full Article

Harbin Pharmaceutical Group's Controlling Shareholder To Sell Stake In The Company
Monday, 27 May 2019 

May 27 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER PLANS TO SELL 20% STAKE FOR 1.7 BILLION YUAN ($246.45 million) TO UP TO THREE SHAREHOLDERS.  Full Article

UPDATE 1-US senator asks for CFIUS review of GNC purchase by Chinese company

WASHINGTON, Sept 10 U.S. Senator Marco Rubio, a Republican and a China hawk, asked for a national security review of plans by General Nutrition Centers, or GNC, to sell itself to Harbin Pharmaceutical Group Co Ltd.